Coexpression	O
of	O
NF-kappa	B-protein
B/Rel	I-protein
and	O
Sp1	B-protein
transcription	B-protein
factors	I-protein
in	O
human	O
immunodeficiency	O
virus	O
1-induced	O
,	O
dendritic	O
cell-T-cell	O
syncytia	O
.	O

Productive	O
infection	O
of	O
T	B-cell_type
cells	I-cell_type
with	O
human	O
immunodeficiency	O
virus	O
1	O
(	O
HIV-1	O
)	O
typically	O
requires	O
that	O
the	O
T	B-cell_type
cells	I-cell_type
be	O
stimulated	O
with	O
antigens	O
or	O
mitogens	O
.	O

This	O
requirement	O
has	O
been	O
attributed	O
to	O
the	O
activation	O
of	O
the	O
transcription	B-protein
factor	I-protein
NF-kappa	B-protein
B	I-protein
,	O
which	O
synergizes	O
with	O
the	O
constitutive	B-protein
transcription	I-protein
factor	I-protein
Sp1	B-protein
to	O
drive	O
the	O
HIV-1	B-DNA
promoter	I-DNA
.	O

Recently	O
,	O
we	O
have	O
found	O
that	O
vigorous	O
replication	O
of	O
HIV-1	O
takes	O
place	O
in	O
nonactivated	O
memory	B-cell_type
T	I-cell_type
cells	I-cell_type
after	O
syncytium	O
formation	O
with	O
dendritic	B-cell_type
cells	I-cell_type
(	O
DCs	B-cell_type
)	O
.	O

These	O
syncytia	O
lack	O
activated	B-cell_type
cells	I-cell_type
as	O
determined	O
by	O
an	O
absence	O
of	O
staining	O
for	O
Ki-67	O
cell	O
cycle	O
antigen	O
.	O

The	O
expression	O
and	O
activity	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
Sp1	B-protein
were	O
,	O
therefore	O
,	O
analyzed	O
in	O
isolated	O
T	B-cell_type
cells	I-cell_type
and	O
DCs	B-cell_type
from	O
humans	O
and	O
mice	O
.	O

We	O
have	O
used	O
immunolabeling	O
,	O
Western	O
blot	O
analysis	O
,	O
and	O
electrophoretic	O
mobility	O
shift	O
and	O
supershift	O
assays	O
.	O

T	B-cell_type
cells	I-cell_type
lack	O
active	O
NF-kappa	B-protein
B	I-protein
but	O
express	O
Sp1	B-protein
as	O
expected	O
.	O

DCs	B-cell_type
express	O
high	O
levels	O
of	O
all	O
known	O
NF-kappa	B-protein
B	I-protein
and	O
Rel	B-protein
proteins	I-protein
,	O
with	O
activity	O
residing	O
primarily	O
within	O
RelB	B-protein
,	O
p50	B-protein
,	O
and	O
p65	B-protein
.	O

However	O
,	O
DCs	B-cell_type
lack	O
Sp1	B-protein
,	O
which	O
may	O
explain	O
the	O
failure	O
of	O
HIV-1	O
to	O
replicate	O
in	O
purified	O
DCs	B-cell_type
.	O

Coexpression	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
Sp1	B-protein
occurs	O
in	O
the	O
heterologous	B-cell_type
DC-T-cell	I-cell_type
syncytia	I-cell_type
that	O
are	O
induced	O
by	O
HIV-1	O
.	O

Therefore	O
,	O
HIV-1-induced	O
cell	O
fusion	O
brings	O
together	O
factors	O
that	O
upregulate	O
virus	O
transcription	O
.	O

Since	O
DCs	B-cell_type
and	O
memory	O
T	B-cell_type
cells	I-cell_type
frequently	O
traffic	O
together	O
in	O
situ	O
,	O
these	O
unusual	O
heterologous	B-cell_type
syncytia	I-cell_type
could	O
develop	O
in	O
infected	O
individuals	O
and	O
lead	O
to	O
chronic	O
HIV-1	O
replication	O
without	O
ostensible	O
immune	O
stimulation	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

92	NULL
,	NULL
pp	NULL
.	NULL

10944-10948	NULL
,	NULL
November	NULL
1995	NULL
Medical	NULL
Sciences	NULL
Coexpression	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
and	NULL
Spl	NULL
transcription	NULL
factors	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
l-induced	NULL
,	NULL
dendritic	NULL
cell-T-cell	NULL
syncytia	NULL
ANGELA	NULL
GRANELLI-PIPERNO*	NULL
,	NULL
MELISSA	NULL
POPE*	NULL
,	NULL
KaYyo	NULL
INABAT	NULL
,	NULL
AND	NULL
RALPH	NULL
M.	NULL
STEINMAN®*	NULL
*Laboratory	NULL
of	NULL
Cellular	NULL
Physiology	NULL
and	NULL
Immunology	NULL
,	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Zoology	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Kyoto	NULL
606-01	NULL
,	NULL
Japan	NULL
Communicated	NULL
by	NULL
David	NULL
J.	NULL
L.	NULL
Luck	NULL
,	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
August	NULL
3	NULL
,	NULL
1995	NULL
ABSTRACT	NULL
Productive	NULL
infection	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
typically	NULL
requires	NULL
that	NULL
the	NULL
T	NULL
cells	NULL
be	NULL
stimulated	NULL
with	NULL
antigens	NULL
or	NULL
mitogens	NULL
.	NULL

This	NULL
requirement	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
which	NULL
synergizes	NULL
with	NULL
the	NULL
constitutive	NULL
transcription	NULL
factor	NULL
Sp1	NULL
to	NULL
drive	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
vigorous	NULL
replication	NULL
of	NULL
HIV-1	NULL
takes	NULL
place	NULL
in	NULL
nonactivated	NULL
memory	NULL
T	NULL
cells	NULL
after	NULL
syncytium	NULL
formation	NULL
with	NULL
dendritic	NULL
cells	NULL
(	NULL
DCs	NULL
)	NULL
.	NULL

These	NULL
syncytia	NULL
lack	NULL
activated	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
an	NULL
absence	NULL
of	NULL
staining	NULL
for	NULL
Ki-67	NULL
cell	NULL
cycle	NULL
antigen	NULL
.	NULL

The	NULL
expression	NULL
and	NULL
activity	NULL
of	NULL
NF-xB	NULL
and	NULL
Sp1	NULL
were	NULL
,	NULL
therefore	NULL
,	NULL
analyzed	NULL
in	NULL
isolated	NULL
T	NULL
cells	NULL
and	NULL
DCs	NULL
from	NULL
humans	NULL
and	NULL
mice	NULL
.	NULL

We	NULL
have	NULL
used	NULL
immunolabeling	NULL
,	NULL
Western	NULL
blot	NULL
anal-ysis	NULL
,	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
and	NULL
supershift	NULL
assays	NULL
.	NULL

T	NULL
cells	NULL
lack	NULL
active	NULL
but	NULL
express	NULL
Spl	NULL
as	NULL
expected	NULL
.	NULL

DCs	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
all	NULL
known	NULL
NF-xB	NULL
and	NULL
Rel	NULL
proteins	NULL
,	NULL
with	NULL
activity	NULL
residing	NULL
primarily	NULL
within	NULL
RelB	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
.	NULL

However	NULL
,	NULL
DCs	NULL
lack	NULL
Sp1	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
the	NULL
failure	NULL
of	NULL
HIV-1	NULL
to	NULL
replicate	NULL
in	NULL
purified	NULL
DCs	NULL
.	NULL

Coexpression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
occurs	NULL
in	NULL
the	NULL
heterologous	NULL
DC-T-cell	NULL
syncytia	NULL
that	NULL
are	NULL
induced	NULL
by	NULL
HIV-1	NULL
.	NULL

Therefore	NULL
,	NULL
HIV-1-induced	NULL
cell	NULL
fusion	NULL
brings	NULL
together	NULL
factors	NULL
that	NULL
upregulate	NULL
virus	NULL
transcription	NULL
.	NULL

Since	NULL
DCs	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
frequently	NULL
traffic	NULL
together	NULL
in	NULL
situ	NULL
,	NULL
these	NULL
unusual	NULL
heterologous	NULL
syncytia	NULL
could	NULL
develop	NULL
in	NULL
infected	NULL
individuals	NULL
and	NULL
lead	NULL
to	NULL
chronic	NULL
HIV-1	NULL
replication	NULL
without	NULL
ostensible	NULL
immune	NULL
stimulation	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
replicates	NULL
in	NULL
cultured	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
stimulated	NULL
by	NULL
antigens	NULL
or	NULL
mitogens	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Stimulation	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
Rel	NULL
transcription	NULL
factors	NULL
(	NULL
5	NULL
)	NULL
,	NULL
which	NULL
can	NULL
then	NULL
drive	NULL
corresponding	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
promoter	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
HIV-1	NULL
promoter	NULL
also	NULL
contains	NULL
essential	NULL
Spl	NULL
sites	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
but	NULL
Sp1	NULL
factors	NULL
are	NULL
expressed	NULL
constitutively	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
most	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
anti-genic	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
may	NULL
not	NULL
be	NULL
essential	NULL
for	NULL
HIV-1	NULL
replication	NULL
in	NULL
infected	NULL
individuals	NULL
.	NULL

For	NULL
example	NULL
,	NULL
these	NULL
individuals	NULL
lose	NULL
T-cell	NULL
memory	NULL
for	NULL
antigens	NULL
to	NULL
which	NULL
they	NULL
are	NULL
no	NULL
longer	NULL
being	NULL
exposed	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Recent	NULL
data	NULL
on	NULL
the	NULL
substantial	NULL
rate	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
vivo	NULL
also	NULL
suggests	NULL
some	NULL
stable	NULL
chronic	NULL
stimulus	NULL
for	NULL
virus	NULL
replication	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
need	NULL
for	NULL
T-cell	NULL
activation	NULL
for	NULL
HIV-1	NULL
replication	NULL
became	NULL
of	NULL
interest	NULL
to	NULL
us	NULL
when	NULL
we	NULL
identified	NULL
a	NULL
system	NULL
in	NULL
which	NULL
mixtures	NULL
of	NULL
dendritic	NULL
cells	NULL
(	NULL
DCs	NULL
)	NULL
and	NULL
small-sized	NULL
T	NULL
cells	NULL
,	NULL
carrying	NULL
a	NULL
memory	NULL
phenotype	NULL
,	NULL
supported	NULL
vigorous	NULL
infections	NULL
with	NULL
HIV-1	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
T	NULL
lym-phocytes	NULL
did	NULL
not	NULL
show	NULL
critical	NULL
features	NULL
of	NULL
cell	NULL
activation	NULL
since	NULL
there	NULL
was	NULL
an	NULL
absence	NULL
of	NULL
the	NULL
Ki-67	NULL
cell	NULL
cycle	NULL
antigen	NULL
,	NULL
surface	NULL
interleukin	NULL
2	NULL
receptors	NULL
,	NULL
and	NULL
HLA-DR	NULL
antigens	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

When	NULL
these	NULL
mixtures	NULL
of	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
several	NULL
different	NULL
isolates	NULL
of	NULL
HIV-1	NULL
,	NULL
the	NULL
newly	NULL
synthesized	NULL
HIV-1	NULL
gag	NULL
proteins	NULL
and	NULL
virions	NULL
were	NULL
confined	NULL
to	NULL
heterologous	NULL
syncytia	NULL
(	NULL
DCs	NULL
+	NULL
T	NULL
cells	NULL
)	NULL
that	NULL
were	NULL
induced	NULL
by	NULL
the	NULL
virus	NULL
(	NULL
13	NULL
)	NULL
.	NULL

These	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

10944	NULL
permissive	NULL
syncytia	NULL
were	NULL
formed	NULL
with	NULL
all	NULL
seven	NULL
HIV-1	NULL
isolates	NULL
that	NULL
we	NULL
tested	NULL
,	NULL
including	NULL
those	NULL
that	NULL
were	NULL
classified	NULL
as	NULL
nonsyn-cytium	NULL
inducing	NULL
in	NULL
standard	NULL
test	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
show	NULL
herein	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
DC-T-cell	NULL
syncytia	NULL
brings	NULL
together	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
Rel	NULL
proteins	NULL
via	NULL
the	NULL
DC	NULL
with	NULL
Spl	NULL
via	NULL
the	NULL
nonactivated	NULL
T	NULL
cell	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
HIV-1	NULL
to	NULL
induce	NULL
heterologous	NULL
syncytia	NULL
may	NULL
lead	NULL
to	NULL
chronic	NULL
unremitting	NULL
virus	NULL
replication	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
standard	NULL
stimuli	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Antibodies	NULL
.	NULL

Antibodies	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
and	NULL
to	NULL
Sp1	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
;	NULL
anti-Ki-67	NULL
(	NULL
MIB-1	NULL
)	NULL
was	NULL
from	NULL
AMAC	NULL
(	NULL
Westbrook	NULL
,	NULL
ME	NULL
)	NULL
;	NULL
anti-HIV-1	NULL
p24	NULL
(	NULL
15	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
The	NULL
AIDS	NULL
Research	NULL
and	NULL
Reagent	NULL
Program	NULL
.	NULL

Cell	NULL
Preparations	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
flotation	NULL
on	NULL
Ficoll/Hypaque	NULL
and	NULL
separated	NULL
into	NULL
cell	NULL
subsets	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Mixed	NULL
leukocyte	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
1	NULL
x	NULL
10°	NULL
responding	NULL
T	NULL
cells	NULL
and	NULL
3	NULL
X	NULL
10°	NULL
allogeneic	NULL
DCs	NULL
.	NULL

Skin	NULL
cell	NULL
emigrants	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Mouse	NULL
cells	NULL
(	NULL
DCs	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
thioglycollate-elicited	NULL
macro-phages	NULL
)	NULL
were	NULL
prepared	NULL
by	NULL
standard	NULL
methods	NULL
.	NULL

Bone	NULL
marrow	NULL
DCs	NULL
were	NULL
grown	NULL
with	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
from	NULL
progenitors	NULL
as	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Infection	NULL
of	NULL
Cell	NULL
Suspensions	NULL
.	NULL

Mixtures	NULL
of	NULL
allogeneic	NULL
blood	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
mixed	NULL
leukocyte	NULL
reaction	NULL
)	NULL
or	NULL
1	NULL
X	NULL
10°	NULL
viable	NULL
skin	NULL
cell	NULL
emigrants	NULL
were	NULL
added	NULL
to	NULL
wells	NULL
of	NULL
a	NULL
96-well	NULL
round-bottom	NULL
well	NULL
plate	NULL
.	NULL

Live	NULL
was	NULL
added	NULL
for	NULL
1.5	NULL
h	NULL
at	NULL
37°C	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.05-0.1	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
cultured	NULL
for	NULL
5-6	NULL
days	NULL
.	NULL

Immunolabeling	NULL
of	NULL
Cells	NULL
.	NULL

For	NULL
immunocytochemistry	NULL
,	NULL
the	NULL
slides	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
the	NULL
primary	NULL
antibody	NULL
(	NULL
0.3	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
bound	NULL
antibody	NULL
was	NULL
detected	NULL
by	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibody	NULL
and	NULL
diaminoben-zidine	NULL
.	NULL

For	NULL
immunofluorescence	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
primary	NULL
antibody	NULL
(	NULL
0.3	NULL
ug/ml	NULL
)	NULL
followed	NULL
by	NULL
fluorescein	NULL
isothio-cyanate-coupled	NULL
anti-mouse	NULL
or	NULL
Texas	NULL
red-coupled	NULL
anti-rabbit	NULL
immunoglobulin	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
10	NULL
ug	NULL
of	NULL
cell	NULL
lysates	NULL
.	NULL

Primary	NULL
antibody	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
was	NULL
added	NULL
in	NULL
5	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
milk	NULL
.	NULL

Proteins	NULL
were	NULL
visualized	NULL
with	NULL
ECL	NULL
.	NULL

DNA-Protein	NULL
Binding	NULL
[	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
]	NULL
Assay	NULL
.	NULL

The	NULL
EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
SP1	NULL
,	NULL
5	NULL
!	NULL

-ATTCGATCGGGGCGGGGCGAGC-3	NULL
'	NULL
;	NULL
SP1	NULL
mutant	NULL
,	NULL
5	NULL
!	NULL

-ATTCGATCGGTITTCGGGGCGAGC-3	NULL
'	NULL
;	NULL
NF-kB	NULL
,	NULL
5'-AGTTGAGGGGACTTTCCCAGGC-3	NULL
'	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
mutant	NULL
,	NULL
5-AGTTGAGGCGACTTTCCCAGG-3	NULL
'	NULL
(	NULL
mutations	NULL
are	NULL
under-lined	NULL
)	NULL
.	NULL

Nuclear	NULL
and	NULL
cytosolic	NULL
fractions	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
Abbreviations	NULL
:	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
DC	NULL
,	NULL
dendritic	NULL
cell	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Granelli-Piperno	NULL
et	NULL
al	NULL
.	NULL

standard	NULL
protocol	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

From	NULL
3	NULL
to	NULL
10	NULL
ug	NULL
of	NULL
proteins	NULL
was	NULL
used	NULL
for	NULL
each	NULL
reaction	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
.	NULL

The	NULL
template	NULL
and	NULL
the	NULL
conditions	NULL
of	NULL
the	NULL
assay	NULL
were	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
template	NULL
carries	NULL
the	NULL
HIV-1	NULL
promoter	NULL
sequences	NULL
from	NULL
positions	NULL
-109	NULL
to	NULL
-~8	NULL
followed	NULL
by	NULL
the	NULL
adenoviruses	NULL
major	NULL
late	NULL
initiator	NULL
element	NULL
from	NULL
positions	NULL
-7	NULL
to	NULL
+9	NULL
and	NULL
a	NULL
379-bp	NULL
G-free	NULL
cassette	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
25-75	NULL
ug	NULL
)	NULL
were	NULL
used	NULL
in	NULL
these	NULL
reactions	NULL
.	NULL

Recombinant	NULL
Spl	NULL
was	NULL
from	NULL
Promega	NULL
.	NULL

RESULTS	NULL
HIV-1	NULL
Replicates	NULL
in	NULL
Mixtures	NULL
of	NULL
DCs	NULL
and	NULL
T	NULL
Cells	NULL
in	NULL
the	NULL
Absence	NULL
of	NULL
Cell	NULL
Proliferation	NULL
.	NULL

It	NULL
was	NULL
first	NULL
essential	NULL
to	NULL
extend	NULL
the	NULL
evidence	NULL
that	NULL
T-cell	NULL
proliferation	NULL
is	NULL
not	NULL
required	NULL
for	NULL
HIV-1	NULL
replication	NULL
in	NULL
mixtures	NULL
of	NULL
DCs	NULL
and	NULL
ostensible	NULL
nonactivated	NULL
T	NULL
cells	NULL
from	NULL
skin	NULL
.	NULL

Skin	NULL
was	NULL
chosen	NULL
since	NULL
in	NULL
many	NULL
respects	NULL
it	NULL
resembles	NULL
the	NULL
lining	NULL
of	NULL
the	NULL
organs	NULL
involved	NULL
in	NULL
sexual	NULL
transmission	NULL
of	NULL
HIV-1	NULL
,	NULL
and	NULL
both	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
chronically	NULL
traffic	NULL
in	NULL
cutaneous	NULL
afferent	NULL
lymphatics	NULL
(	NULL
21	NULL
)	NULL
.	NULL

HIV-1	NULL
was	NULL
added	NULL
to	NULL
skin	NULL
cell	NULL
emigrants	NULL
or	NULL
antigen-stimulated	NULL
blood	NULL
cells	NULL
.	NULL

Both	NULL
cultures	NULL
became	NULL
infected	NULL
,	NULL
as	NULL
monitored	NULL
by	NULL
the	NULL
release	NULL
of	NULL
p24	NULL
antigen	NULL
and	NULL
reverse	NULL
transcriptase	NULL
into	NULL
the	NULL
culture	NULL
medium	NULL
(	NULL
13	NULL
,	NULL
22	NULL
)	NULL
,	NULL
but	NULL
it	NULL
was	NULL
not	NULL
necessary	NULL
to	NULL
add	NULL
a	NULL
stimulus	NULL
to	NULL
the	NULL
skin	NULL
cultures	NULL
(	NULL
13	NULL
)	NULL
.	NULL

HIV-1-infected	NULL
syncytia	NULL
from	NULL
both	NULL
blood	NULL
and	NULL
skin	NULL
expressed	NULL
p24	NULL
antigen	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
4	NULL
and	NULL
C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
nuclei	NULL
of	NULL
the	NULL
skin	NULL
syncytia	NULL
lacked	NULL
the	NULL
Ki-67	NULL
antigen	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
cycling	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
nuclei	NULL
of	NULL
the	NULL
blood	NULL
cell	NULL
syncytia	NULL
were	NULL
all	NULL
Ki-67-positive	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
with	NULL
D	NULL
)	NULL
.	NULL

In	NULL
two	NULL
experiments	NULL
,	NULL
100	NULL
%	NULL
of	NULL
the	NULL
nuclei	NULL
(	NULL
85	NULL
counted	NULL
)	NULL
in	NULL
skin	NULL
syncytia	NULL
lacked	NULL
Ki-67	NULL
,	NULL
whereas	NULL
94	NULL
%	NULL
of	NULL
the	NULL
nuclei	NULL
(	NULL
57	NULL
counted	NULL
)	NULL
in	NULL
blood-cell	NULL
syncytia	NULL
expressed	NULL
Ki-67	NULL
.	NULL

Therefore	NULL
,	NULL
standard	NULL
T-cell	NULL
activating	NULL
stimuli	NULL
,	NULL
which	NULL
are	NULL
required	NULL
for	NULL
HIV-1	NULL
replication	NULL
in	NULL
isolated	NULL
blood	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
22	NULL
)	NULL
,	NULL
are	NULL
unlikely	NULL
to	NULL
be	NULL
needed	NULL
for	NULL
replication	NULL
in	NULL
these	NULL
mixtures	NULL
of	NULL
DCs	NULL
and	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Spl	NULL
Proteins	NULL
in	NULL
Leukocytes	NULL
.	NULL

Given	NULL
the	NULL
essential	NULL
role	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Rel	NULL
family	NULL
)	NULL
and	NULL
Spt	NULL
sites	NULL
in	NULL
(	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
,	NULL
we	NULL
set	NULL
out	NULL
to	NULL
study	NULL
the	NULL
expression	NULL
of	NULL
Rel	NULL
and	NULL
Sp1	NULL
factors	NULL
in	NULL
different	NULL
subsets	NULL
of	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

HIV-l-infected	NULL
syncytia	NULL
contain	NULL
cycling	NULL
cells	NULL
from	NULL
blood	NULL
and	NULL
noncycling	NULL
cells	NULL
from	NULL
skin	NULL
.	NULL

Mixtures	NULL
of	NULL
allogeneic	NULL
blood	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
mixed	NULL
leukocyte	NULL
reactions	NULL
)	NULL
or	NULL
syngeneic	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
skin	NULL
were	NULL
infected	NULL
with	NULL
HIV-1jmg	NULL
.	NULL

Cytocentrifuged	NULL
cells	NULL
were	NULL
prepared	NULL
after	NULL
5	NULL
days	NULL
of	NULL
infection	NULL
and	NULL
immunoperoxidase-stained	NULL
for	NULL
p24	NULL
and	NULL
Ki-67	NULL
.	NULL

Skin	NULL
syncytia	NULL
were	NULL
stained	NULL
for	NULL
HIV	NULL
p24	NULL
antigen	NULL
(	NULL
4	NULL
)	NULL
or	NULL
Ki-67	NULL
cell	NULL
cycle	NULL
antigen	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Blood	NULL
mixed	NULL
leukocyte	NULL
reaction	NULL
syncytia	NULL
were	NULL
stained	NULL
for	NULL
HIV	NULL
p24	NULL
(	NULL
C	NULL
)	NULL
or	NULL
Ki-67	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
nuclei	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
-	NULL
10945	NULL
A	NULL
p6éSs	NULL
C	NULL
Rel	NULL
ns	NULL
sme	NULL
site	NULL
|	NULL
mae	NULL
Rel	NULL
B	NULL
=*	NULL
-_	NULL
-=	NULL
a	NULL
»	NULL
NFKB	NULL
.	NULL

ppGS	NULL
.	NULL

«	NULL
#	NULL
»	NULL
slie	NULL
dite	NULL
«	NULL
«	NULL
NFKB	NULL
p50	NULL
«	NULL
=	NULL
«	NULL
#	NULL
«	NULL
«	NULL
»	NULL
SP1	NULL
=¥	NULL
an	NULL
ar	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Expression	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
and	NULL
Sp1	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
DCs	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Immunofluorescence	NULL
.	NULL

Cytocentrifuged	NULL
DCs	NULL
(	NULL
Left	NULL
)	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
Right	NULL
)	NULL
were	NULL
immunolabeled	NULL
with	NULL
antibodies	NULL
to	NULL
Rel	NULL
proteins	NULL
or	NULL
Sp1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
subsets	NULL
of	NULL
mouse	NULL
leukocytes	NULL
,	NULL
peritoneal	NULL
macrophages	NULL
(	NULL
Mq	NULL
)	NULL
,	NULL
spleen	NULL
(	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
bone	NULL
marrow	NULL
DCs	NULL
(	NULL
BMDC	NULL
)	NULL
were	NULL
probed	NULL
with	NULL
antibodies	NULL
to	NULL
the	NULL
indicated	NULL
Rel	NULL
family	NULL
and	NULL
Sp1	NULL
proteins	NULL
.	NULL

Bound	NULL
antibodies	NULL
were	NULL
visualized	NULL
with	NULL
peroxidase	NULL
anti-immunoglobulin	NULL
,	NULL
followed	NULL
by	NULL
ECL	NULL
.	NULL

10946	NULL
_	NULL
Medical	NULL
Sciences	NULL
:	NULL
Granelli-Piperno	NULL
et	NULL
al	NULL
.	NULL

human	NULL
and	NULL
mouse	NULL
leukocytes	NULL
,	NULL
especially	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
by	NULL
immunolabeling	NULL
.	NULL

All	NULL
Rel	NULL
family	NULL
proteins	NULL
were	NULL
readily	NULL
identified	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
nuclei	NULL
of	NULL
HLA-DR-positive	NULL
DCs	NULL
from	NULL
human	NULL
blood	NULL
,	NULL
but	NULL
Sp1	NULL
was	NULL
not	NULL
detectable	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
Left	NULL
)	NULL
.	NULL

Previously	NULL
only	NULL
Drosophila	NULL
cells	NULL
were	NULL
known	NULL
to	NULL
lack	NULL
Sp1	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Contrasting	NULL
findings	NULL
were	NULL
made	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
human	NULL
blood	NULL
.	NULL

Cells	NULL
stained	NULL
weakly	NULL
and	NULL
primarily	NULL
in	NULL
the	NULL
cytoplasm	NULL
with	NULL
antibodies	NULL
to	NULL
the	NULL
Rel	NULL
family	NULL
members	NULL
,	NULL
but	NULL
Sp1	NULL
was	NULL
abundant	NULL
in	NULL
all	NULL
T-cell	NULL
nuclei	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
Right	NULL
)	NULL
.	NULL

Both	NULL
cytofluorography	NULL
and	NULL
immunocytochemistry	NULL
for	NULL
Rel	NULL
and	NULL
Sp1	NULL
gave	NULL
the	NULL
same	NULL
results	NULL
on	NULL
mouse	NULL
spleen	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
presented	NULL
above	NULL
for	NULL
human	NULL
blood	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
high	NULL
levels	NULL
of	NULL
Rel	NULL
proteins	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
Sp1	NULL
in	NULL
DCs	NULL
and	NULL
vice	NULL
versa	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
used	NULL
immunoblot	NULL
analysis	NULL
to	NULL
detect	NULL
these	NULL
proteins	NULL
in	NULL
different	NULL
cell	NULL
subsets	NULL
from	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
and	NULL
human	NULL
blood	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Purified	NULL
DCs	NULL
that	NULL
were	NULL
generated	NULL
from	NULL
proliferating	NULL
bone	NULL
mar	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
row	NULL
progenitors	NULL
(	NULL
17	NULL
)	NULL
contained	NULL
all	NULL
Rel	NULL
proteins	NULL
but	NULL
lacked	NULL
Sp1	NULL
.	NULL

T	NULL
and	NULL
B	NULL
cells	NULL
from	NULL
spleen	NULL
and	NULL
macrophages	NULL
elicited	NULL
into	NULL
the	NULL
peritoneal	NULL
cavity	NULL
had	NULL
abundant	NULL
Sp1	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
and	NULL
Sp1	NULL
Binding	NULL
Activities	NULL
in	NULL
Blood	NULL
Cells	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
these	NULL
transcriptional	NULL
control	NULL
proteins	NULL
was	NULL
then	NULL
assessed	NULL
with	NULL
a	NULL
consensus	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
and	NULL
EMSA	NULL
applied	NULL
to	NULL
several	NULL
subsets	NULL
of	NULL
leukocytes	NULL
.	NULL

Data	NULL
are	NULL
shown	NULL
for	NULL
human	NULL
blood	NULL
leukocytes	NULL
,	NULL
but	NULL
comparable	NULL
findings	NULL
were	NULL
made	NULL
with	NULL
mouse	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
primarily	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
vs.	NULL
cytoplasm	NULL
in	NULL
every	NULL
cell	NULL
type	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
activity	NULL
was	NULL
ablated	NULL
by	NULL
a	NULL
wild-type	NULL
competing	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
a	NULL
mutated	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

NF-KB	NULL
activity	NULL
was	NULL
greatly	NULL
enhanced	NULL
by	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
phytohemagglutinin	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
)	NULL
and	NULL
monocytes	NULL
(	NULL
lipopolysaccharide	NULL
)	NULL
,	NULL
but	NULL
B	NULL
cells	NULL
and	NULL
DCs	NULL
had	NULL
readily	NULL
detectable	NULL
NF-KB	NULL
activity	NULL
in	NULL
the	NULL
A	NULL
T	NULL
Unst	NULL
T	NULL
Stim	NULL
cyt	NULL
NE	NULL
cyt	NULL
NE	NULL
m	NULL
m	NULL
m	NULL
m	NULL
Comp	NULL
:	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
Mo	NULL
Unst	NULL
Mo	NULL
Stim	NULL
cyt	NULL
NE	NULL
cyt	NULL
NE	NULL
m	NULL
m	NULL
m	NULL
m	NULL
Comp	NULL
:	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
i	NULL
dane	NULL
B	NULL
DC	NULL
cyt	NULL
NE	NULL
cyt	NULL
NE	NULL
m	NULL
m	NULL
m	NULL
m	NULL
Comp	NULL
:	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
-	NULL
kB	NULL
kB	NULL
C	NULL
T	NULL
B	NULL
DC	NULL
cyt	NULL
NE	NULL
NE	NULL
cyt	NULL
NE	NULL
NE	NULL
cyt	NULL
NE	NULL
NE	NULL
cyt	NULL
NE	NULL
Stim	NULL
:	NULL
-o	NULL
-	NULL
-	NULL
e	NULL
#	NULL
#	NULL
-	NULL
-	NULL
-	NULL
-~	NULL
Comp	NULL
:	NULL
SP1	NULL
SP1	NULL
SP1	NULL
i	NULL
Mo	NULL
Unst	NULL
Mo	NULL
LPS	NULL
cyt	NULL
NE	NULL
cyt	NULL
NE	NULL
m	NULL
m	NULL
m	NULL
m	NULL
-	NULL
SP1SP1	NULL
-	NULL
SP1SP1	NULL
-	NULL
SP1SP1	NULL
-	NULL
SP1	NULL
SP1	NULL
*	NULL
witt	NULL
than	NULL
Comp	NULL
:	NULL
B	NULL
a	NULL
-	NULL
2	NULL
&	NULL
s	NULL
©	NULL
o	NULL
u	NULL
Ab	NULL
:	NULL
-	NULL
a	NULL
E	NULL
6	NULL
8	NULL
§	NULL
0	NULL
-	NULL
2	NULL
€	NULL
DC	NULL
T	NULL
Stim	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Activity	NULL
of	NULL
Rel	NULL
proteins	NULL
and	NULL
Spl	NULL
in	NULL
human	NULL
leukocyte	NULL
subsets	NULL
.	NULL

(	NULL
4	NULL
)	NULL
EMSA	NULL
with	NULL
NF-kB	NULL
consensus	NULL
sequences	NULL
and	NULL
proteins	NULL
from	NULL
the	NULL
cytoplasm	NULL
(	NULL
cyt	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
(	NULL
NE	NULL
)	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
DCs	NULL
that	NULL
had	NULL
been	NULL
enriched	NULL
from	NULL
human	NULL
blood	NULL
.	NULL

The	NULL
T	NULL
cells	NULL
were	NULL
studied	NULL
without	NULL
(	NULL
unst	NULL
)	NULL
or	NULL
with	NULL
(	NULL
stim	NULL
)	NULL
stimulation	NULL
with	NULL
phytohemagglutinin	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
phorbol	NULL
12-myristate	NULL
l3-acetate	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
for	NULL
12	NULL
h.	NULL
Monocytes	NULL
were	NULL
studied	NULL
without	NULL
or	NULL
with	NULL
stimulation	NULL
with	NULL
lipopolysaccharide	NULL
(	NULL
100	NULL
pg/ml	NULL
)	NULL
.	NULL

To	NULL
establish	NULL
specificity	NULL
,	NULL
each	NULL
gel	NULL
shift	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
50	NULL
%	NULL
molar	NULL
excess	NULL
of	NULL
competing	NULL
wild-type	NULL
(	NULL
kB	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
mkB	NULL
)	NULL
oligonucleo-tides	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Supershift	NULL
EMSA	NULL
assays	NULL
to	NULL
identify	NULL
the	NULL
active	NULL
Rel	NULL
family	NULL
members	NULL
in	NULL
DCs	NULL
and	NULL
stimulated	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Each	NULL
EMSA	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
antiserum	NULL
(	NULL
-	NULL
)	NULL
,	NULL
with	NULL
preimmune	NULL
serum	NULL
(	NULL
P.1	NULL
.	NULL
)	NULL

,	NULL
or	NULL
with	NULL
antibodies	NULL
to	NULL
RelB	NULL
,	NULL
c-Rel	NULL
,	NULL
p50	NULL
,	NULL
or	NULL
p65	NULL
.	NULL

Supershifted	NULL
bands	NULL
are	NULL
shown	NULL
with	NULL
an	NULL
asterisk	NULL
.	NULL

Results	NULL
with	NULL
two	NULL
experiments	NULL
with	NULL
DC	NULL
nuclear	NULL
extracts	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
with	NULL
Spl	NULL
consensus	NULL
sequences	NULL
and	NULL
proteins	NULL
from	NULL
the	NULL
cytoplasm	NULL
and	NULL
nuclear	NULL
extracts	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
+	NULL
stimulation	NULL
with	NULL
phytohem-agglutinin/phorbol	NULL
12-myristate	NULL
13-acetate	NULL
)	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
DCs	NULL
,	NULL
and	NULL
macrophages	NULL
(	NULL
mg	NULL
)	NULL
that	NULL
were	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
competing	NULL
wild-type	NULL
(	NULL
SP1	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
mSP1	NULL
)	NULL
oligonucleotide	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Granelli-Piperno	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
-	NULL
10947	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Expression	NULL
of	NULL
Rel	NULL
and	NULL
Spl	NULL
proteins	NULL
in	NULL
mixtures	NULL
of	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
skin	NULL
.	NULL

Explants	NULL
of	NULL
skin	NULL
were	NULL
cultured	NULL
for	NULL
4	NULL
days	NULL
and	NULL
emigrate	NULL
cells	NULL
were	NULL
cytocentrifuged	NULL
and	NULL
stained	NULL
with	NULL
immunoperoxidase	NULL
for	NULL
c-Rel	NULL
,	NULL
RelB	NULL
,	NULL
p65	NULL
,	NULL
Spl	NULL
,	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
.	NULL

The	NULL
large	NULL
DCs	NULL
are	NULL
readily	NULL
distinguished	NULL
from	NULL
the	NULL
small	NULL
T	NULL
cells	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
indicated	NULL
with	NULL
arrows	NULL
.	NULL

absence	NULL
of	NULL
experimental	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
NF-KB	NULL
binding	NULL
activity	NULL
detected	NULL
in	NULL
DCs	NULL
was	NULL
not	NULL
inhibited	NULL
when	NULL
extracts	NULL
of	NULL
unstimulated	NULL
T	NULL
cells	NULL
were	NULL
added	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
DC	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
is	NULL
dominant	NULL
over	NULL
that	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
.	NULL

f	NULL
Supershift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
to	NULL
identify	NULL
the	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
in	NULL
human	NULL
blood	NULL
DCs	NULL
and	NULL
stimulated	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
standard	NULL
NF-	NULL
«	NULL
B	NULL
EMSA	NULL
assays	NULL
,	NULL
the	NULL
p65	NULL
and	NULL
p50	NULL
components	NULL
of	NULL
the	NULL
heterodimer	NULL
migrate	NULL
as	NULL
separate	NULL
species	NULL
.	NULL

Antibodies	NULL
to	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
Rel-B	NULL
produced	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
corresponding	NULL
NF-	NULL
«	NULL
B	NULL
species	NULL
from	NULL
DCs	NULL
,	NULL
whereas	NULL
strong	NULL
supershifts	NULL
in	NULL
stimulated	NULL
T	NULL
cells	NULL
were	NULL
observed	NULL
with	NULL
anti-p50	NULL
and	NULL
anti-p65	NULL
.	NULL

For	NULL
Spl	NULL
EMSA	NULL
assays	NULL
,	NULL
activity	NULL
was	NULL
noted	NULL
in	NULL
unstimulated	NULL
T	NULL
cells	NULL
and	NULL
stimulated	NULL
macrophages	NULL
but	NULL
was	NULL
weak	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
not	NULL
detectable	NULL
in	NULL
DCs	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
detectable	NULL
binding	NULL
of	NULL
DC	NULL
nuclear	NULL
extracts	NULL
to	NULL
the	NULL
Spl	NULL
consensus	NULL
sequence	NULL
suggested	NULL
that	NULL
Sp2	NULL
and	NULL
Sp3	NULL
(	NULL
25	NULL
)	NULL
were	NULL
also	NULL
absent	NULL
in	NULL
these	NULL
extracts	NULL
.	NULL

Detection	NULL
of	NULL
NF-B/Rel	NULL
and	NULL
Spl	NULL
Proteins	NULL
in	NULL
Skin	NULL
Cells	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

and	NULL
Sp1	NULL
in	NULL
populations	NULL
of	NULL
cells	NULL
isolated	NULL
from	NULL
skin	NULL
.	NULL

These	NULL
contain	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
that	NULL
form	NULL
tight	NULL
conjugates	NULL
and	NULL
are	NULL
permissive	NULL
to	NULL
HIV-1	NULL
(	NULL
13	NULL
)	NULL
.	NULL

For	NULL
both	NULL
mouse	NULL
and	NULL
human	NULL
skin	NULL
,	NULL
the	NULL
DCs	NULL
are	NULL
large	NULL
and	NULL
Rel	NULL
B	NULL
irregularly	NULL
shaped	NULL
,	NULL
while	NULL
the	NULL
T	NULL
cells	NULL
are	NULL
small	NULL
and	NULL
round	NULL
.	NULL

The	NULL
DCs	NULL
are	NULL
known	NULL
to	NULL
be	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II-bright	NULL
and	NULL
CD3-negative	NULL
,	NULL
while	NULL
the	NULL
T	NULL
cells	NULL
are	NULL
class	NULL
II	NULL
negative	NULL
and	NULL
CD3-positive	NULL
.	NULL

In	NULL
cells	NULL
from	NULL
mouse	NULL
and	NULL
human	NULL
skin	NULL
,	NULL
the	NULL
large	NULL
DCs	NULL
showed	NULL
strong	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
labeling	NULL
with	NULL
antibodies	NULL
to	NULL
all	NULL
the	NULL
Rel	NULL
family	NULL
members	NULL
(	NULL
c-Rel	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
p65	NULL
,	NULL
shown	NULL
here	NULL
,	NULL
but	NULL
also	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
no	NULL
labeling	NULL
with	NULL
anti-Sp1	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
T	NULL
cells	NULL
showed	NULL
weak	NULL
labeling	NULL
with	NULL
all	NULL
anti-Rel	NULL
antibodies	NULL
except	NULL
p65	NULL
,	NULL
but	NULL
strong	NULL
nuclear	NULL
labeling	NULL
with	NULL
anti-Sp1	NULL
.	NULL

Syncytia	NULL
of	NULL
HIV-l-Infected	NULL
Skin	NULL
Cells	NULL
Coexpress	NULL
NF-	NULL
«	NULL
B	NULL
/Rel	NULL
and	NULL
Sp1	NULL
Transcription	NULL
Factors	NULL
.	NULL

The	NULL
studies	NULL
were	NULL
then	NULL
repeated	NULL
on	NULL
HIV-1-infected	NULL
human	NULL
skin	NULL
cells	NULL
.	NULL

These	NULL
cultures	NULL
contained	NULL
numerous	NULL
syncytia	NULL
.	NULL

Prior	NULL
work	NULL
had	NULL
shown	NULL
that	NULL
the	NULL
syncytia	NULL
are	NULL
heterologous	NULL
(	NULL
double	NULL
labeling	NULL
with	NULL
the	NULL
CD1a	NULL
marker	NULL
for	NULL
DCs	NULL
and	NULL
the	NULL
CD3	NULL
marker	NULL
for	NULL
T	NULL
cells	NULL
)	NULL
and	NULL
are	NULL
the	NULL
major	NULL
site	NULL
of	NULL
viral	NULL
replication	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
three	NULL
typical	NULL
syncytia	NULL
that	NULL
were	NULL
double	NULL
labeled	NULL
for	NULL
the	NULL
Rel	NULL
proteins	NULL
(	NULL
visualized	NULL
by	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
antibody	NULL
)	NULL
and	NULL
Spl	NULL
(	NULL
visualized	NULL
by	NULL
Texas	NULL
red-conjugated	NULL
antibody	NULL
)	NULL
.	NULL

These	NULL
syncytia	NULL
show	NULL
RelB	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
staining	NULL
,	NULL
p50	NULL
being	NULL
the	NULL
strongest	NULL
.	NULL

Spl	NULL
is	NULL
in	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
¥	NULL
p50/SP1	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Coexpression	NULL
of	NULL
NF-kB/Rel	NULL
and	NULL
Sp1	NULL
proteins	NULL
in	NULL
heterologous	NULL
syncytia	NULL
of	NULL
skin	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Shown	NULL
here	NULL
is	NULL
double	NULL
immuno-fluorescent	NULL
labeling	NULL
of	NULL
syncytia	NULL
for	NULL
RelB	NULL
(	NULL
green	NULL
)	NULL
and	NULL
Spl	NULL
(	NULL
red	NULL
)	NULL
on	NULL
the	NULL
left	NULL
or	NULL
p65	NULL
(	NULL
green	NULL
)	NULL
and	NULL
Sp1	NULL
(	NULL
red	NULL
)	NULL
on	NULL
the	NULL
right	NULL
or	NULL
superimposed	NULL
staining	NULL
of	NULL
p50	NULL
and	NULL
Sp1	NULL
on	NULL
the	NULL
right	NULL
in	NULL
the	NULL
lower	NULL
box	NULL
.	NULL

Some	NULL
T-cell	NULL
nuclei	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

10948	NULL
_	NULL
Medical	NULL
Sciences	NULL
:	NULL
Granelli-Piperno	NULL
et	NULL
al	NULL
.	NULL

N	NULL
o	NULL
%	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Cooperation	NULL
of	NULL
DC	NULL
extracts	NULL
and	NULL
&	NULL
«	NULL
&	NULL
o	NULL
``	NULL
4	NULL
O	NULL
Qt	NULL
Sp1	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
25-75	NULL
ug	NULL
)	NULL
from	NULL
the	NULL
indicated	NULL
cells	NULL
were	NULL
tested	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
transactivate	NULL
the	NULL
HIV-1	NULL
promoter	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
.	NULL

DC	NULL
extracts	NULL
were	NULL
assayed	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
Sp1	NULL
(	NULL
1	NULL
footprinting	NULL
unit	NULL
)	NULL
.	NULL

The	NULL
transcribed	NULL
RNA	NULL
was	NULL
purified	NULL
,	NULL
resolved	NULL
in	NULL
a	NULL
urea/PAGE	NULL
gel	NULL
,	NULL
and	NULL
autoradiographed	NULL
.	NULL

An	NULL
arrow	NULL
indicates	NULL
the	NULL
expected	NULL
size	NULL
of	NULL
tran-scripts	NULL
.	NULL

nuclei	NULL
in	NULL
these	NULL
syncytia	NULL
,	NULL
presumably	NULL
those	NULL
derived	NULL
from	NULL
the	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
efficiency	NULL
with	NULL
which	NULL
virus	NULL
replicates	NULL
in	NULL
skin	NULL
syncytia	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
colocalization	NULL
of	NULL
these	NULL
requisite	NULL
transcription	NULL
control	NULL
proteins	NULL
for	NULL
HIV-1	NULL
in	NULL
the	NULL
syncytia	NULL
.	NULL

DC	NULL
Nuclear	NULL
Extracts	NULL
Transactivate	NULL
the	NULL
HIV-1	NULL
Promoter	NULL
.	NULL

We	NULL
have	NULL
looked	NULL
at	NULL
the	NULL
ability	NULL
of	NULL
DC	NULL
and	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
to	NULL
activate	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
HeLa	NULL
and	NULL
stimulated	NULL
T	NULL
cells	NULL
show	NULL
transcriptional	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
DC	NULL
nuclear	NULL
extracts	NULL
needed	NULL
to	NULL
be	NULL
supplemented	NULL
with	NULL
Sp1	NULL
to	NULL
drive	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

DISCUSSION	NULL
Prior	NULL
studies	NULL
in	NULL
cell	NULL
lines	NULL
have	NULL
identified	NULL
an	NULL
important	NULL
role	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp1	NULL
proteins	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
HIV-1	NULL
(	NULL
6	NULL
,	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

In	NULL
primary	NULL
cells	NULL
,	NULL
both	NULL
monocytes	NULL
and	NULL
T	NULL
cells	NULL
will	NULL
support	NULL
replication	NULL
of	NULL
HIV-1	NULL
,	NULL
but	NULL
the	NULL
cells	NULL
must	NULL
be	NULL
stimulated	NULL
,	NULL
presumably	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
thereby	NULL
initiate	NULL
HIV-1	NULL
transcription	NULL
.	NULL

DCs	NULL
contain	NULL
high	NULL
levels	NULL
of	NULL
all	NULL
known	NULL
Rel	NULL
family	NULL
members	NULL
and	NULL
express	NULL
strong	NULL
activity	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
DNA	NULL
binding	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
stimulation	NULL
with	NULL
,	NULL
for	NULL
example	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
during	NULL
DC	NULL
de-velopment	NULL
.	NULL

However	NULL
,	NULL
DCs	NULL
lack	NULL
Spl	NULL
,	NULL
whereas	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
express	NULL
Sp1	NULL
in	NULL
an	NULL
active	NULL
form	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
made	NULL
with	NULL
DCs	NULL
from	NULL
human	NULL
blood	NULL
and	NULL
skin	NULL
,	NULL
as	NULL
well	NULL
as	NULL
mouse	NULL
spleen	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
and	NULL
skin	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
Sp1	NULL
could	NULL
account	NULL
for	NULL
the	NULL
fact	NULL
that	NULL
isolated	NULL
DCs	NULL
do	NULL
not	NULL
support	NULL
a	NULL
productive	NULL
infection	NULL
with	NULL
HIV-1	NULL
(	NULL
13	NULL
,	NULL
22	NULL
,	NULL
28	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
from	NULL
several	NULL
sites	NULL
,	NULL
which	NULL
also	NULL
do	NULL
not	NULL
support	NULL
productive	NULL
HIV-1	NULL
infection	NULL
unless	NULL
stimulated	NULL
,	NULL
lack	NULL
active	NULL
Rel	NULL
proteins	NULL
but	NULL
have	NULL
abundant	NULL
Spl	NULL
.	NULL

When	NULL
HIV-1	NULL
infects	NULL
mixtures	NULL
of	NULL
DCs	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
and	NULL
possibly	NULL
,	NULL
when	NULL
DCs	NULL
conjugate	NULL
to	NULL
``	NULL
latently	NULL
``	NULL
infected	NULL
T	NULL
cells	NULL
and	NULL
vice	NULL
versa	NULL
)	NULL
,	NULL
expression	NULL
of	NULL
low	NULL
levels	NULL
of	NULL
envelope	NULL
proteins	NULL
might	NULL
mediate	NULL
cell	NULL
fusion	NULL
via	NULL
the	NULL
CD4	NULL
molecule	NULL
that	NULL
can	NULL
be	NULL
expressed	NULL
by	NULL
either	NULL
cell	NULL
type	NULL
.	NULL

As	NULL
a	NULL
result	NULL
of	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
unusual	NULL
heterologous	NULL
syncytia	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
active	NULL
Rel	NULL
and	NULL
Spl	NULL
proteins	NULL
are	NULL
brought	NULL
together	NULL
into	NULL
the	NULL
same	NULL
cell	NULL
.	NULL

The	NULL
HIV-1	NULL
promoter	NULL
should	NULL
then	NULL
be	NULL
stimulated	NULL
strongly	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
marked	NULL
production	NULL
of	NULL
virions	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
standard	NULL
stimuli	NULL
.	NULL

DCs	NULL
are	NULL
present	NULL
in	NULL
the	NULL
linings	NULL
of	NULL
all	NULL
of	NULL
the	NULL
organs	NULL
involved	NULL
in	NULL
the	NULL
sexual	NULL
transmission	NULL
of	NULL
HIV-1	NULL
,	NULL
while	NULL
DC-T-cell	NULL
conjugates	NULL
are	NULL
found	NULL
in	NULL
the	NULL
afferent	NULL
lymphatics	NULL
of	NULL
all	NULL
four	NULL
mammalian	NULL
species	NULL
that	NULL
have	NULL
been	NULL
studied	NULL
including	NULL
humans	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
refs	NULL
.	NULL

29-33	NULL
)	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
HIV-1	NULL
to	NULL
create	NULL
heterologous	NULL
syncytia	NULL
between	NULL
these	NULL
two	NULL
CD4*	NULL
cell	NULL
types	NULL
can	NULL
bring	NULL
together	NULL
requisite	NULL
transcriptional	NULL
control	NULL
proteins	NULL
for	NULL
the	NULL
viral	NULL
promoter	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
phenomenon	NULL
of	NULL
heterologous	NULL
syncytia	NULL
and	NULL
mixing	NULL
of	NULL
transcriptional	NULL
control	NULL
proteins	NULL
has	NULL
not	NULL
been	NULL
seen	NULL
previously	NULL
in	NULL
viral	NULL
infection	NULL
(	NULL
or	NULL
other	NULL
circumstances	NULL
)	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
chronic	NULL
HIV-1	NULL
replication	NULL
in	NULL
sifu	NULL
.	NULL

We	NULL
thank	NULL
D.	NULL
Chen	NULL
and	NULL
A.	NULL
Mirza	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
AI-24775	NULL
,	NULL
the	NULL
Dorothy	NULL
Schiff	NULL
Foundation	NULL
,	NULL
the	NULL
Adopt	NULL
an	NULL
AIDS	NULL
Researcher	NULL
Program	NULL
,	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
and	NULL
by	NULL
the	NULL
Grant-in-Aid	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
of	NULL
Japan	NULL
to	NULL
K.I	NULL
.	NULL

M.P	NULL
.	NULL

is	NULL
a	NULL
Norman	NULL
and	NULL
Rosita	NULL
Winston	NULL
Fellow	NULL
.	NULL

1	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

McDougal	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Mawle	NULL
,	NULL
A.	NULL
,	NULL
Cort	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Nicholson	NULL
,	NULL
J.	NULL
K.	NULL
A.	NULL
,	NULL
Cross	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Scheppler-Campbell	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Hicks	NULL
,	NULL
D.	NULL
&	NULL
Sligh	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

135	NULL
,	NULL
3151-3162	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Dukovich	NULL
,	NULL
M.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
238	NULL
,	NULL
1575-1578	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

Zack	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Arrigo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Weitsman	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Go	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Haislip	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
213-222	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Azarenko	NULL
,	NULL
V.	NULL
,	NULL
Tomita	NULL
,	NULL
Y.	NULL
M.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
&	NULL
Siebentist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

182	NULL
,	NULL
411-420	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Edwards	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Agranoff	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Schmid	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3551-3558	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
232	NULL
,	NULL
755-759	NULL
.	NULL

Briggs	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Bell	NULL
,	NULL
S.	NULL
P.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
234	NULL
,	NULL
47-52	NULL
.	NULL

Murray	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
Welte	NULL
,	NULL
K.	NULL
,	NULL
Jacobs	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Rubin	NULL
,	NULL
B.	NULL
Y.	NULL
,	NULL
Mertels-mann	NULL
,	NULL
R.	NULL
&	NULL
Roberts	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

76	NULL
,	NULL
1959-1964	NULL
.	NULL

Lane	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Whalen	NULL
,	NULL
G.	NULL
,	NULL
Wald-mann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1985	NULL
)	NULL
New	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

313	NULL
,	NULL
79-84	NULL
.	NULL

Ho	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Neumann	NULL
,	NULL
A.	NULL
U.	NULL
,	NULL
Perelson	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
W.	NULL
,	NULL
Leonard	NULL
,	NULL
J.	NULL
M.	NULL
&	NULL
Markowitz	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
373	NULL
,	NULL
123-126	NULL
.	NULL

Wei	NULL
,	NULL
X.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Taylor	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Johnson	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Emini	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Deutsch	NULL
,	NULL
P.	NULL
,	NULL
Lifson	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Bonhoeffer	NULL
,	NULL
S.	NULL
,	NULL
Nowak	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Hahn	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Saag	NULL
,	NULL
M.	NULL
S.	NULL
&	NULL
Shaw	NULL
,	NULL
G.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
373	NULL
,	NULL
117-122	NULL
.	NULL

Pope	NULL
,	NULL
M.	NULL
,	NULL
Betjes	NULL
,	NULL
M.	NULL
G.	NULL
H.	NULL
,	NULL
Romani	NULL
,	NULL
N.	NULL
,	NULL
Hirmand	NULL
,	NULL
H.	NULL
,	NULL
Cameron	NULL
,	NULL
P.	NULL
U.	NULL
,	NULL
Hoffman	NULL
,	NULL
L.	NULL
,	NULL
Gezelter	NULL
,	NULL
S.	NULL
,	NULL
Schuler	NULL
,	NULL
G.	NULL
&	NULL
Steinman	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
389-398	NULL
.	NULL

Pope	NULL
,	NULL
M.	NULL
,	NULL
Betjes	NULL
,	NULL
M.	NULL
G.	NULL
H.	NULL
,	NULL
Hirmand	NULL
,	NULL
H.	NULL
,	NULL
Hoffman	NULL
,	NULL
L.	NULL
&	NULL
Steinman	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

104	NULL
,	NULL
11-18	NULL
.	NULL

Chesebro	NULL
,	NULL
B.	NULL
,	NULL
Wehrly	NULL
,	NULL
K.	NULL
,	NULL
Nishio	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Perryman	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
6547-6554	NULL
.	NULL

Freudenthal	NULL
,	NULL
P.	NULL
S.	NULL
&	NULL
Steinman	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
$	NULL
7	NULL
,	NULL
7698-7702	NULL
.	NULL

Inaba	NULL
,	NULL
K.	NULL
,	NULL
Inaba	NULL
,	NULL
M.	NULL
,	NULL
Romani	NULL
,	NULL
N.	NULL
,	NULL
Aya	NULL
,	NULL
H.	NULL
,	NULL
Deguchi	NULL
,	NULL
M.	NULL
,	NULL
Ikehara	NULL
,	NULL
S.	NULL
,	NULL
Muramatsu	NULL
,	NULL
S.	NULL
&	NULL
Steinman	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
1693-1702	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Nolan	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
2734-2739	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Kretzschmar	NULL
,	NULL
M.	NULL
,	NULL
Meisterernst	NULL
,	NULL
M.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
Li	NULL
,	NULL
G.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
761-774	NULL
.	NULL

Mackay	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Marston	NULL
,	NULL
W.	NULL
L.	NULL
&	NULL
Dudler	NULL
,	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
801-818	NULL
.	NULL

Cameron	NULL
,	NULL
P.	NULL
U.	NULL
,	NULL
Freudenthal	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Barker	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Gezelter	NULL
,	NULL
S.	NULL
,	NULL
Inaba	NULL
,	NULL
K.	NULL
&	NULL
Steinman	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
383-387	NULL
.	NULL

Gerdes	NULL
,	NULL
J.	NULL
,	NULL
Lemke	NULL
,	NULL
H.	NULL
,	NULL
Baisch	NULL
,	NULL
H.	NULL
,	NULL
Wacker	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
Schwabb	NULL
,	NULL
U	NULL
.	NULL

&	NULL
Stein	NULL
,	NULL
H.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

133	NULL
,	NULL
1710-1715	NULL
.	NULL

Courey	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
887-898	NULL
.	NULL

Kingsley	NULL
,	NULL
C.	NULL
&	NULL
Winoto	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4251-4261	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Agranoff	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Pascal	NULL
,	NULL
E.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6570-6583	NULL
.	NULL

Ross	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
Buckler-White	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Rabson	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Englund	NULL
,	NULL
G.	NULL
&	NULL
Martin	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
4350-4358	NULL
.	NULL

Weissman	NULL
,	NULL
D.	NULL
,	NULL
Li	NULL
,	NULL
Y.	NULL
,	NULL
Ananworanich	NULL
,	NULL
J.	NULL
,	NULL
Zhou	NULL
,	NULL
L.-J	NULL
.	NULL

,	NULL
Adels-berger	NULL
,	NULL
J.	NULL
,	NULL
Tedder	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
Baseler	NULL
,	NULL
M.	NULL
&	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
826-830	NULL
.	NULL

Steinman	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Hoffman	NULL
,	NULL
L.	NULL
&	NULL
Pope	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

105	NULL
,	NULL
2S-8S	NULL
.	NULL

Drexhage	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Mullink	NULL
,	NULL
H.	NULL
,	NULL
de	NULL
Groot	NULL
,	NULL
J.	NULL
,	NULL
Clarke	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Balfour	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1979	NULL
)	NULL
Cell	NULL
Tissue	NULL
Res	NULL
.	NULL

202	NULL
,	NULL
407-430	NULL
.	NULL

Mackay	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Hein	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
Brown	NULL
,	NULL
M.	NULL
H.	NULL
&	NULL
Matzinger	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

18	NULL
,	NULL
1681-1688	NULL
.	NULL

Galkowska	NULL
,	NULL
H.	NULL
&	NULL
Olszewski	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Lymphology	NULL
25	NULL
,	NULL
106-113	NULL
.	NULL

Brand	NULL
,	NULL
C.	NULL
U.	NULL
,	NULL
Hunziker	NULL
,	NULL
T.	NULL
,	NULL
Schaffner	NULL
,	NULL
T.	NULL
,	NULL
Gerber	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
&	NULL
Braathen	NULL
,	NULL
L.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
in	NULL
Dendritic	NULL
Cells	NULL
in	NULL
Fundamental	NULL
and	NULL
Clinical	NULL
Immunology	NULL
,	NULL
eds	NULL
.	NULL

Banchereau	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Schmitt	NULL
,	NULL
D.	NULL
(	NULL
Plenum	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

523-525	NULL
.	NULL

